Exact Mass: 364.10526500000003
Exact Mass Matches: 364.10526500000003
Found 124 metabolites which its exact mass value is equals to given mass value 364.10526500000003
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
10-HCPT
10-Hydroxycamptothecin is a pyranoindolizinoquinoline. 10-hydroxycamptothecin is under investigation in clinical trial NCT00956787 (Study of AR-67 (DB-67) in Myelodysplastic Syndrome (MDS)). 10-Hydroxycamptothecin is a natural product found in Nothapodytes nimmoniana, Camptotheca acuminata, and Fusarium solani with data available. D000970 - Antineoplastic Agents (S)-10-Hydroxycamptothecin (10-HCPT;10-Hydroxycamptothecin) is a DNA topoisomerase I inhibitor of isolated from the Chinese plant Camptotheca accuminata. (S)-10-Hydroxycamptothecin exhibits a remarkable apoptosis-inducing effect. (S)-10-Hydroxycamptothecin has the potential for hepatoma, gastric carcinoma, colon cancer and leukaemia treatment[1][2][3][4]. (S)-10-Hydroxycamptothecin (10-HCPT;10-Hydroxycamptothecin) is a DNA topoisomerase I inhibitor of isolated from the Chinese plant Camptotheca accuminata. (S)-10-Hydroxycamptothecin exhibits a remarkable apoptosis-inducing effect. (S)-10-Hydroxycamptothecin has the potential for hepatoma, gastric carcinoma, colon cancer and leukaemia treatment[1][2][3][4].
bumetanide
C17H20N2O5S (364.10928700000005)
D045283 - Natriuretic Agents > D004232 - Diuretics > D049994 - Sodium Potassium Chloride Symporter Inhibitors C - Cardiovascular system > C03 - Diuretics > C03C - High-ceiling diuretics > C03CA - Sulfonamides, plain C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49184 - Loop Diuretic D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D049990 - Membrane Transport Modulators KEIO_ID B093; [MS2] KO009094 KEIO_ID B093; [MS3] KO009095 KEIO_ID B093
Bumetanide
C17H20N2O5S (364.10928700000005)
Bumetanide is only found in individuals that have used or taken this drug. It is a sulfamyl diuretic.Bumetanide interferes with renal cAMP and/or inhibits the sodium-potassium ATPase pump. Bumetanide appears to block the active reabsorption of chloride and possibly sodium in the ascending loop of Henle, altering electrolyte transfer in the proximal tubule. This results in excretion of sodium, chloride, and water and, hence, diuresis. D045283 - Natriuretic Agents > D004232 - Diuretics > D049994 - Sodium Potassium Chloride Symporter Inhibitors C - Cardiovascular system > C03 - Diuretics > C03C - High-ceiling diuretics > C03CA - Sulfonamides, plain C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49184 - Loop Diuretic D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D049990 - Membrane Transport Modulators
10-Hydroxycamptothecin
N-Hydroxy-2-(N-isopropoxybiphenyl-4-ylsulfonamido)acetamide
C17H20N2O5S (364.10928700000005)
(E)-1-(4-((6-Amino-5-((methoxyimino)methyl)pyrimidin-4-yl)oxy)-2-chlorophenyl)-3-ethylurea
Lykurim
C10H24N2O8S2 (364.09740239999996)
D000970 - Antineoplastic Agents
Pheneticillin
C17H20N2O5S (364.10928700000005)
18-bromooctadeca-5,7,17-triynoic acid methyl ester
C19H25BrO2 (364.10378099999997)
1,3-Bis-(1-semicarbazono-2-carboxy-aethyl)-benzol|3,3-Disemicarbazono-3,3-m-phenylen-di-propionsaeure|3,3-disemicarbazono-3,3-m-phenylene-di-propionic acid
(-)-(5R,6S)-5-carbamoyl-5-beta-D-glucopyranosyloxy-6-hydroxy-4-methoxy-1-methyl-5,6-dihydro-2-pyridone|acalyphin amide
C13H20N2O10 (364.11179000000004)
methyl ester of 18-bromooctadeca-5,7,17-triynoic acid
C19H25BrO2 (364.10378099999997)
Me ether-(15Z,17E)-18-Bromo-15,17-octadecadiene-5,7-diynoic acid|Methyl 18-Bromo-(15Z,17E)-octadeca-15,17-diene-5,7-diynoate
C19H25BrO2 (364.10378099999997)
4-Ethyl-4,12-dihydroxy-1H-pyrano(3,4:6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione
Pheneticillin;alpha-Phenoxyethylpenicillin
C17H20N2O5S (364.10928700000005)
Hydroxy camptothecine
D000970 - Antineoplastic Agents (±)-10-Hydroxycamptothecin is an indole alkaloid that inhibits the activity of topoisomerase I and has a broad spectrum of anticancer activity. (±)-10-Hydroxycamptothecin is an indole alkaloid that inhibits the activity of topoisomerase I and has a broad spectrum of anticancer activity.
10-Hydroxycamptothecin
SubCategory_DNP: : Alkaloids derived from anthranilic acid, Quinoline alkaloids relative retention time with respect to 9-anthracene Carboxylic Acid is 0.944 D000970 - Antineoplastic Agents relative retention time with respect to 9-anthracene Carboxylic Acid is 0.947 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.929 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.928 (S)-10-Hydroxycamptothecin (10-HCPT;10-Hydroxycamptothecin) is a DNA topoisomerase I inhibitor of isolated from the Chinese plant Camptotheca accuminata. (S)-10-Hydroxycamptothecin exhibits a remarkable apoptosis-inducing effect. (S)-10-Hydroxycamptothecin has the potential for hepatoma, gastric carcinoma, colon cancer and leukaemia treatment[1][2][3][4]. (S)-10-Hydroxycamptothecin (10-HCPT;10-Hydroxycamptothecin) is a DNA topoisomerase I inhibitor of isolated from the Chinese plant Camptotheca accuminata. (S)-10-Hydroxycamptothecin exhibits a remarkable apoptosis-inducing effect. (S)-10-Hydroxycamptothecin has the potential for hepatoma, gastric carcinoma, colon cancer and leukaemia treatment[1][2][3][4].
Ala Cys Asp Gly
C12H20N4O7S (364.10526500000003)
Ala Cys Gly Asp
C12H20N4O7S (364.10526500000003)
Ala Asp Cys Gly
C12H20N4O7S (364.10526500000003)
Ala Asp Gly Cys
C12H20N4O7S (364.10526500000003)
Ala Gly Cys Asp
C12H20N4O7S (364.10526500000003)
Ala Gly Asp Cys
C12H20N4O7S (364.10526500000003)
Cys Ala Asp Gly
C12H20N4O7S (364.10526500000003)
Cys Ala Gly Asp
C12H20N4O7S (364.10526500000003)
Cys Asp Ala Gly
C12H20N4O7S (364.10526500000003)
Cys Asp Gly Ala
C12H20N4O7S (364.10526500000003)
Cys Glu Gly Gly
C12H20N4O7S (364.10526500000003)
Cys Gly Ala Asp
C12H20N4O7S (364.10526500000003)
Cys Gly Asp Ala
C12H20N4O7S (364.10526500000003)
Cys Gly Glu Gly
C12H20N4O7S (364.10526500000003)
Cys Gly Gly Glu
C12H20N4O7S (364.10526500000003)
Asp Ala Cys Gly
C12H20N4O7S (364.10526500000003)
Asp Ala Gly Cys
C12H20N4O7S (364.10526500000003)
Asp Cys Ala Gly
C12H20N4O7S (364.10526500000003)
Asp Cys Gly Ala
C12H20N4O7S (364.10526500000003)
Asp Gly Ala Cys
C12H20N4O7S (364.10526500000003)
Asp Gly Cys Ala
C12H20N4O7S (364.10526500000003)
Glu Cys Gly Gly
C12H20N4O7S (364.10526500000003)
Glu Gly Cys Gly
C12H20N4O7S (364.10526500000003)
Glu Gly Gly Cys
C12H20N4O7S (364.10526500000003)
Gly Ala Cys Asp
C12H20N4O7S (364.10526500000003)
Gly Ala Asp Cys
C12H20N4O7S (364.10526500000003)
Gly Cys Ala Asp
C12H20N4O7S (364.10526500000003)
Gly Cys Asp Ala
C12H20N4O7S (364.10526500000003)
Gly Cys Glu Gly
C12H20N4O7S (364.10526500000003)
Gly Cys Gly Glu
C12H20N4O7S (364.10526500000003)
Gly Asp Ala Cys
C12H20N4O7S (364.10526500000003)
Gly Asp Cys Ala
C12H20N4O7S (364.10526500000003)
Gly Glu Cys Gly
C12H20N4O7S (364.10526500000003)
Gly Glu Gly Cys
C12H20N4O7S (364.10526500000003)
Gly Gly Cys Glu
C12H20N4O7S (364.10526500000003)
Gly Gly Glu Cys
C12H20N4O7S (364.10526500000003)
PHENETHICILLIN
C17H20N2O5S (364.10928700000005)
A penicillin in which the substituent at position 6 of the penam ring is a 2-phenoxypropanamido group.
ARP-100
C17H20N2O5S (364.10928700000005)
Methyl 18-bromo-15E,17E-octadecadien-5,7-diynoate
C19H25BrO2 (364.10378099999997)
2,3-DIPHENYL-5-(4-METHOXYPHENYL)TETRAZOLIUM CHLORIDE
ethyl 4-methyl-2-[4-(2-methylpropoxy)-3-nitrophenyl]-1,3-thiazole-5-carboxylate
C17H20N2O5S (364.10928700000005)
5-{[1-(Phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]methyl}-2-py ridinamine
pheneticillin
C17H20N2O5S (364.10928700000005)
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CE - Beta-lactamase sensitive penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
3,14-Dioxa-2,15-dithia-6,11-diazahexadecane-8,9-diol,2,2,15,15-tetraoxide, (8R,9S)-rel-
C10H24N2O8S2 (364.09740239999996)
5-(1-Piperazinyl)-2-benzofurancarboxylic acid ethyl ester dihydrochloride hydrate
C15H18N2O3.2(HCl).H2O (364.0956552)
ethyl 2-[3-(1H-benzimidazol-2-yl)-2-oxochromen-7-yl]oxyacetate
(E)-1-(4-((6-Amino-5-((methoxyimino)methyl)pyrimidin-4-yl)oxy)-2-chlorophenyl)-3-ethylurea
(E)-[4-(3,5-Difluorophenyl)-3h-Pyrrolo[2,3-B]pyridin-3-Ylidene](3-Methoxyphenyl)methanol
C21H14F2N2O2 (364.10232879999995)
N1-(1-benzyl-4-piperidyl)-4-chlorobenzene-1-sulfonamide
C18H21ClN2O2S (364.10121960000004)
N-(6-methyl-1,3-benzothiazol-2-yl)-6-oxo-1-phenyl-4,5-dihydropyridazine-3-carboxamide
3-ethyl-2-{[(4-hydroxy-2-quinazolinyl)methyl]thio}-4(3H)-quinazolinone
3-(Benzenesulfonyl)-1-cyclopropyl-2-pyrrolo[3,2-b]quinoxalinamine
2-[[5-(2-Benzofuranyl)-4-(phenylmethyl)-1,2,4-triazol-3-yl]thio]acetamide
3-chloro-N-[4-[(1-oxo-2-phenylethyl)amino]phenyl]benzamide
1-(3-Methoxyphenyl)-3-[[3-(4-nitro-1-pyrazolyl)-1-oxopropyl]amino]thiourea
(2S,5S,6R)-3,3-dimethyl-7-oxo-6-(2-phenoxypropanoylamino)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
C17H20N2O5S (364.10928700000005)
methyl 18-bromooctadeca-5,7,16-triynoate
C19H25BrO2 (364.10378099999997)
methyl (17e)-18-bromooctadeca-15,17-dien-5,7-diynoate
C19H25BrO2 (364.10378099999997)